Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 39 - General protective or antinoxious agents
Patents for A61P 39 - General protective or antinoxious agents (19,019)
12/2003
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/09/2003US6660748 1-azabicyclo(2.2.1)heptane or quinuclidine derivatives; treating or preventing neuronal damage associated with neurological diseases
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/04/2003WO2003099845A2 Fas peptide mimetics and uses thereof
12/04/2003WO2003099808A1 Substituted heterocyclic compounds and methods of use
12/04/2003WO2003099806A1 Creatine salt having enhanced nutritional, antioxidant and therapeutic efficacy and compositions containing same
12/04/2003WO2003099788A1 Piperidine derivatives
12/04/2003WO2003099762A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003WO2003099759A1 Preparation and application of transhintotalphenolic acid
12/04/2003WO2003099752A1 Gingerol analogues and use thereof
12/04/2003WO2003099309A1 Active fraction having anti-cancer and anti-metastasis isolated from acanthopanax species and fruits
12/04/2003WO2003099308A1 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng
12/04/2003WO2003099256A2 FREE-FLOWING, POWDERY COMPOSITION CONTAINING α-LIPONIC ACID (DERIVATIVES)
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003022217A3 Treatment of excessive radiation (e.g. sunburn) exposure
12/04/2003US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate
12/04/2003US20030225085 For reducing neuronal cell death in response to a traumatic event
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225075 Novel pyrimidone derivatives
12/04/2003US20030225033 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof
12/04/2003CA2490542A1 Fas peptide mimetics and uses thereof
12/04/2003CA2487273A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003CA2485166A1 Substituted pyrimidinone and pyridinone compounds
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/03/2003CN1459448A Preparation method of red sageroot total phenolic acid and its use
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656955 Side effect reduction; synergistic mixture
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003CA2075201C Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained
11/2003
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097056A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003WO2003097032A1 Means for weaning people off smoking and alcohol
11/27/2003WO2003053336A3 Methods for the treatment of peripheral neural and vascular ailments
11/27/2003WO2003050252A3 Heme-regulated eukaryotic initiation factor 2 alpha kinase knockout mice and methods for use
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene
11/27/2003US20030221199 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
11/27/2003US20030220480 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220362 Novel inhibitors of formation of advanced glycation endproducts (AGEs)
11/27/2003US20030220347 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219495 To prevent or reverse hypotension, unstable angina, myocardial infarction or shock caused by the concomitant ingestion of a phosphodiesterase inhibitor such as sildenafil citrate and a NO-donor such as L-arginine or an organic nitrate
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003CA2497601A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/26/2003EP1364051A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363891A2 Anthrone derivatives and their use as jnk inhibitors
11/26/2003EP1210073B1 Sunscreen agent for oral administration
11/26/2003EP1107723B1 A carotenoid composition containing phytoene and phytofluene
11/25/2003US6653347 For therapy
11/25/2003CA2134679C Soluble analogs of probucol
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095424A1 Process for producing shogaol and intermediates for the synthesis thereof
11/20/2003WO2003095403A1 Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity
11/20/2003WO2003094953A1 Oxygen carrier, selected from haemoglobin, myoglobin and their derivatives, for treating organ dysfunction/tissue damage caused by an acute supply deficiency
11/20/2003WO2003094946A1 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
11/20/2003WO2003094942A1 Soluble composition containing sporopollenin and the use thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003US20030216424 Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof
11/20/2003US20030216409 Heteroaryl alkyl piperazine derivatives
11/20/2003US20030216391 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
11/20/2003US20030215831 Renal regulatory elements and methods of use thereof
11/20/2003US20030215781 Containing alkali ions, electrolytes, a buffer, polyol, saccharide and hydroxamic acid derivatives
11/20/2003US20030215452 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/19/2003EP1362586A1 Composition for the treatment of alcohol and smoking withdrawal
11/19/2003EP1362511A1 Protective solution for preventing ischaemia
11/19/2003EP1361864A2 Mucoadhesive pharmaceutical formulations
11/19/2003EP1361863A2 Carotenoid-loaded liposomes
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003CN1456561A Preparations of leucovorin and its carbonates
11/19/2003CN1456210A Products for promoting human lead discharge and preparing method thereof
11/19/2003CN1456174A Anti-anoxia anti-fatigue biological preparation for improving human
11/19/2003CN1127984C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative
11/19/2003CN1127966C 'Hehe' ointment and its preparing process
11/18/2003US6649648 Administering 1-chroman, 1-thiochroman or quinoline derivative as anticarcinogenic or antimetastasis agent
11/17/2003CA2429097A1 Composition of solutions for organ protection
11/13/2003WO2003093456A1 Soya cell strains with high isoflavone content
11/13/2003WO2003092675A1 Drugs for mitigating taxane-induced neurotoxicity
11/13/2003WO2003092647A2 Transport system in biological systems
11/13/2003WO2003092606A2 Cholinesterase inhibitors to prevent injuries caused by chemicals
11/13/2003WO2003066034A3 Use of compounds and compositions derived form olives for protecting cells against dna damage
11/13/2003WO2002064796A8 Butyrylcholinesterase polypeptide variants with increased catalytic efficiency and methods of use
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030211132 Method for reducing radioactivity in the human body
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 191